Multiple Sclerosis Clinical Trials in Chicago

Showing 101-120 of 346 trials

Recovery Legal Care Clinical Trial

NCT06618794

Hospital-Based Violence Intervention Programs (HVIPs) affiliated with trauma centers in the US often focus on individual behavior modification for reduction in re-victimization. There is a lack of reproducible evidence that has demonstrated effectiveness, given the exclusion of addressing inequities in the Social and Structural Determinants of Health (SSDOH), often the root causes of violent injury and preventable homicide. The study investigators created a Medical Legal Partnership (MLP) to partner with an existing HVIP. This novel program offers beside legal assistance to address the SSDOH. The purpose of this study is to evaluate the effectiveness of the HVIP-MLP program in improving violence-related outcomes, legal needs, health-related quality of life, PTSD symptoms, and perceived stress.

Firearm InjuryEconomic ProblemsInjury Traumatic+1 more

University of Chicago500 participantsStarted Feb 2025

Chicago, Illinois, United States

ACTIVE_NOT_RECRUITINGPHASE12.2 miles

Study of Oral LY3410738 in Patients With Advanced Hematologic Malignancies With IDH1 or IDH2 Mutations

NCT04603001

This is an open-label, multi-center Phase 1 study of LY3410738, an oral, covalent isocitrate dehydrogenase (IDH) inhibitor, in patients with IDH1 and/or IDH2-mutant advanced hematologic malignancies who may have received standard therapy

Acute Myeloid Leukemia (AML)Myelodysplastic Syndrome (MDS)Chronic Myelomonocytic Leukemia (CMML)+1 more

Eli Lilly and Company260 participantsStarted Nov 2020

Duarte, California, United States • Los Angeles, California, United States • Sacramento, California, United States +34 more locations

Recovery Legal Care Clinical Trial

Study of Oral LY3410738 in Patients With Advanced Hematologic Malignancies With IDH1 or IDH2 Mutations

Multiple Sclerosis Trials in Other Cities

Study of Xevinapant With Radiation and Chemotherapy for Patients With Head and Neck Cancer

A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas

Remote Therapeutic Monitoring Exercise Tracking

A Study of PF-07260437 in Advanced or Metastatic Solid Tumors

ALTTO (Adjuvant Lapatinib And/Or Trastuzumab Treatment Optimisation) Study; BIG 2-06/N063D

Functional Balance Intervention in Multiple Sclerosis

Relapsing Forms of Multiple Sclerosis (RMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib (SAR442168) (GEMINI 1)

ProVIDE II Bridging Study

Family Spirit Strengths

Observational Study of Persistence on Bafiertam Treatment in Routine Clinical Practice

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Clinical Activity of GSK5733584 for Injection in Participants With Advanced Solid Tumors

A Safety Trial of Lisocabtagene Maraleucel (JCAR017) for Relapsed and Refractory (R/R) B-cell Non-Hodgkin Lymphoma (NHL) in the Outpatient Setting (TRANSCEND-OUTREACH-007)

A Phase 2 Study of ONO-2808 in Patients With Multiple System Atrophy

A Study of Apalutamide (Adjuvant Treatment) and Androgen Deprivation Therapy (ADT) in Participants Who Have Undergone Radical Prostatectomy (RP) for Non-metastatic Prostate Cancer and Who Are at High Risk for Metastases

Assessment of ANK-700 in Patients With Relapsing Remitting Multiple Sclerosis

A Study of JNJ-80038114 in Participants With Advanced Stage Prostate Cancer

SL-279252 (PD1-Fc-OX40L) in Subjects With Advanced Solid Tumors or Lymphomas

Bevonescein to Highlight Nerves in Patients Undergoing Head & Neck Surgery

Other Conditions in Chicago